Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition

Brain Research

Volumn 1396, Issue , 2011, Pages 60-68

  Lv, Lei ^a   Sun, Yan ^b   Han, Xiang ^a   Xu, Cong Cong ^b   Tang, Yu Ping ^a   Dong, Qiang ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

HDAC inhibitor; Histone acetylation; Spinal cord injury; Valproic acid

Indexed keywords

CASPASE 3; HEAT SHOCK PROTEIN 70; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; PROTEIN BCL 2; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HISTONE ACETYLATION; LOCOMOTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; RAT; SHAM PROCEDURE; SPINAL CORD INJURY; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITORS; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES; VALPROIC ACID;

RATTUS; RODENTIA;

EID: 79957769597     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.040     Document Type: Article

References (47)

1. Abel, T., Zukin, R.S., 2008. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8, 57-64.
2. Abematsu, M., Tsujimura, K., Yamano, M., Saito, M., Kohno, K., Kohyama, J., Namihira, M., Komiya, S., Nakashima, K., 2010. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J. Clin. Invest. 120, 3255-3266.
3. Barut, S., Unlu, Y.A., Karaoglan, A., Tuncdemir, M., Dagistanli, F.K., Ozturk, M., Colak, A., 2005. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg. Neurol. 64, 213-220 discussion 220.
4. Basso, D.M., Beattie, M.S., Bresnahan, J.C., 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
5. Brichta, L., Holker, I., Haug, K., Klockgether, T., Wirth, B., 2006. In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann. Neurol. 59, 970-975.
6. Carey, N., La Thangue, N.B., 2006. Histone deacetylase inhibitors: gathering pace. Curr. Opin. Pharmacol. 6, 369-375.
7. Chen, P.S., Wang, C.C., Bortner, C.D., Peng, G.S., Wu, X., Pang, H., Lu, R.B., Gean, P.W., Chuang, D.M., Hong, J.S., 2007. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149, 203-212. (Pubitemid 47488650)
8. Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., Chiu, C.-T., 2009. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591-601.
9. Citron, B.A., Arnold, P.M., Haynes, N.G., Ameenuddin, S., Farooque, M., Santacruz, K., Festoff, B.W., 2008. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury. Spine (Phila Pa 1976) 33, 2269-2277.
10. Collas, P., 2010. The current state of chromatin immunoprecipitation. Mol. Biotechnol. 45, 87-100.
11. Cudkowicz, M.E., Andres, P.L., Macdonald, S.A., Bedlack, R.S., Choudry, R., Brown, R.H., Zhang, H., Schoenfeld, D.A., Shefner, J., Matson, S., Matson, W.R., Ferrante, R.J., Consortium, N.E.A., Natl, V.A.A.R.C., 2009. Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph. Lateral Scler. 10, 99-106.
12. Cui, S.S., Yang, C.P., Bowen, R.C., Bai, O., Li, X.M., Jiang, W., Zhang, X., 2003. Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res. 975, 229-236. (Pubitemid 36588571)
13. Dash, P.K., Orsi, S.A., Zhang, M., Grill, R.J., Pati, S., Zhao, J., Moore, A.N., 2010. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS ONE 5, e11383.
14. Dietz, K.C., Casaccia, P., 2010. HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol. Res. 62, 11-17.
15. Faraco, G., Pancani, T., Formentini, L., Mascagni, P., Fossati, G., Leoni, F., Moroni, F., Chiarugi, A., 2006. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol. Pharmacol. 70, 1876-1884.
16. Feng, H.L., Leng, Y., Ma, C.H., Zhang, J., Ren, M., Chuang, D.M., 2008. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155, 567-572.
17. Fukuchi, M., Nii, T., Ishimaru, N., Minamino, A., Hara, D., Takasaki, I., Tabuchi, A., Tsuda, M., 2009. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci. Res. 65, 35-43.
18. Giffard, R.G., Yenari, M.A., 2004. Many mechanisms for Hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 16, 53-61.
19. Hsieh, J., Nakashima, K., Kuwabara, T., Mejia, E., Gage, F.H., 2004. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl Acad. Sci. U.S.A. 101, 16659-16664.
20. Jeong, M.R., Hashimoto, R., Senatorov, V.V., Fujimaki, K., Ren, M., Lee, M.S., Chuang, D.M., 2003. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett. 542, 74-78.
21. Kanai, H., Sawa, A., Chen, R.W., Leeds, P., Chuang, D.M., 2004. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J. 4, 336-344. (Pubitemid 39341573)
22. Kazantsev, A.G., Thompson, L.M., 2008. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 7, 854-868.
23. Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., Steward, O., 2005. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705. (Pubitemid 40664118)
24. Khalatbary, A.R., Tiraihi, T., Boroujeni, M.B., Ahmadvand, H., Tavafi, M., Tamjidipoor, A., 2010. Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats. Brain Res. 1306, 168-175.
25. Kim, H.J., Rowe, M., Ren, M., Hong, J.S., Chen, P.S., Chuang, D.M., 2007. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321, 892-901.
26. Kouzarides, T., 2007. Chromatin modifications and their function. Cell 128, 693-705. (Pubitemid 46273577)
27. Langley, B., Gensert, J.M., Beal, M.F., Ratan, R.R., 2005. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr. Drug Targets CNS Neurol. Disord. 4, 41-50.
28. Liu, X.Z., Xu, X.M., Hu, R., Du, C., Zhang, S.X., McDonald, J.W., Dong, H.X., Wu, Y.J., Fan, G.S., Jacquin, M.F., Hsu, C.Y., Choi, D.W., 1997. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406. (Pubitemid 27300306)
29. Metz, G.A.S., Merkler, D., Dietz, V., Schwab, M.E., Fouad, K., 2000. Efficient testing of motor function in spinal cord injured rats. Brain Res. 883, 165-177.
30. Nalivaeva, N.N., Belyaev, N.D., Turner, A.J., 2009. Sodium valproate: an old drug with new roles. Trends Pharmacol. Sci. 30, 509-514.
31. Nan, G.X., Li, M., Liao, W.H., Qin, J.Q., Cao, Y.J., Lu, Y.Q., 2009. Effect of valproic acid on endogenous neural stem cell proliferation in a rat model of spinal cord injury. Neural Regen. Res. 4, 513-517.
32. Ouyang, Y.B., Giffard, R.G., 2004. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 36, 303-311. (Pubitemid 38992355)
33. Pearse, D.D., Pereira, F.C., Marcillo, A.E., Bates, M.L., Berrocal, Y.A., Filbin, M.T., Bunge, M.B., 2004. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10, 610-616.
34. Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., Klein, P.S., 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741.
35. Piepers, S., Veldink, J.H., de Jong, S.W., van der Tweel, I., van der Pol, W.L., Uijtendaal, E.V., Schelhaas, H.J., Scheffer, H., de Visser, M., de Jong, J., Wokke, J.H.J., Groeneveld, G.J., van den Berg, L.H., 2009. Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann. Neurol. 66, 227-234.
36. Ren, M., Leng, Y., Jeong, M., Leeds, P.R., Chuang, D.M., 2004. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 89, 1358-1367. (Pubitemid 38802657)
37. Rouaux, C., Panteleeva, I., Rene, F., de Aguilar, J.L.G., Echaniz-Laguna, A., Dupuis, L., Menger, Y., Boutillier, A.L., Loeffler, J.P., 2007. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 27, 5535-5545. (Pubitemid 350021087)
38. Shin, Y.C., Choi, K.Y., Kim, W.G., 2007. Cyclosporin A has a protective effect with induced upregulation of Hsp70 and nNOS on severe spinal cord ischemic injury in rabbits. J. Invest. Surg. 20, 113-120.
39. Sinn, D.I., Kim, S.J., Chu, K., Jung, K.H., Lee, S.T., Song, E.C., Kim, J.M., Park, D.K., Lee, S.K., Kim, M., Roh, J.K., 2007. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol. Dis. 26, 464-472.
40. Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z.W., Sumi, H., Hamasaki, T., Goto, M., Sakoda, S., 2004. Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur. J. Neurosci. 20, 3179-3183.
41. Takami, T., Oudega, M., Bates, M.L., Wood, P.M., Kleitman, N., Bunge, M.B., 2002. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. 22, 6670-6681. (Pubitemid 35386423)
42. Tsai, L.K., Tsai, M.S., Ting, C.H., Li, H., 2008. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice. J. Mol. Med. Jmm. 86, 1243-1254.
43. Yildirim, F., Gertz, K., Golo, K., Harms, C., Fink, K.B., Meisel, A., Endres, M., 2008. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp. Neurol. 210, 531-542.
44. Yune, T.Y., Kim, S.J., Lee, S.M., Lee, Y.K., Oh, Y.J., Kim, Y.C., Markelonis, G.J., Oh, T.H., 2004. Systemic administration of 17 beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 21, 293-306. (Pubitemid 38401751)
45. Yune, T.Y., Park, H.G., Lee, J.Y., Oh, T.H., 2008. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3- kinase/Akt-dependent CREB activation. J. Neurotrauma 25, 1121-1131.
46. Zhang, J.J., Zhang, R.F., Meng, X.K., 2009. Protective effect of pyrroloquinoline quinone against A beta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 464, 165-169.
47. Zhang, Z., Zhang, Z.Y., Fauser, U., Schluesener, H.J., 2008. Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell. Mol. Life Sci. 65, 4055-4065.